(E)-3-(4-(Bis(2-chloroethyl)amino)phenyl)-1-(4-(methylsulfonyl)phenyl)prop-2-en-1-one

ID: ALA4559596

PubChem CID: 155385985

Max Phase: Preclinical

Molecular Formula: C20H21Cl2NO3S

Molecular Weight: 426.37

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)c1ccc(C(=O)/C=C/c2ccc(N(CCCl)CCCl)cc2)cc1

Standard InChI:  InChI=1S/C20H21Cl2NO3S/c1-27(25,26)19-9-5-17(6-10-19)20(24)11-4-16-2-7-18(8-3-16)23(14-12-21)15-13-22/h2-11H,12-15H2,1H3/b11-4+

Standard InChI Key:  RQLHFFBAACFJLF-NYYWCZLTSA-N

Molfile:  

 
     RDKit          2D

 27 28  0  0  0  0  0  0  0  0999 V2000
    2.7776   -4.7504    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3690   -4.0406    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.9601   -4.7478    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0857   -2.8106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0846   -3.6343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7968   -4.0432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5106   -3.6338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5077   -2.8070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7950   -2.3976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2180   -2.3916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9273   -2.8017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6376   -2.3863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3509   -2.7963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2149   -1.5703    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.3509   -3.6165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0635   -4.0224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7747   -3.6111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7690   -2.7855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0559   -2.3793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4886   -4.0160    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.4928   -4.8374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2067   -5.2465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2109   -6.0678    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   10.1984   -3.6038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9082   -4.0088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6179   -3.5966    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.6609   -3.6331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 10 14  2  0
 13 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 13  1  0
 17 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 20 24  1  0
 24 25  1  0
 25 26  1  0
  5  2  1  0
  2 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4559596

    ---

Associated Targets(Human)

MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-468 (9477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Chorioallantoic membrane (375 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 426.37Molecular Weight (Monoisotopic): 425.0619AlogP: 4.27#Rotatable Bonds: 9
Polar Surface Area: 54.45Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.56CX LogP: 4.17CX LogD: 4.17
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.34Np Likeness Score: -0.77

References

1. Elkhalifa D, Siddique AB, Qusa M, Cyprian FS, El Sayed K, Alali F, Al Moustafa AE, Khalil A..  (2020)  Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.,  187  [PMID:31838326] [10.1016/j.ejmech.2019.111954]

Source